These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35146503)

  • 41. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
    Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
    Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Weight, age and coefficients of variation in renal solute excretion.
    Perry GM; Scheinman SJ; Asplin JR
    Nephron Physiol; 2012; 122(1-2):13-8. PubMed ID: 23595094
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypocitraturia in calcium nephrolithiasis.
    Rudman D; Kutner MH; Redd SC; Waters WC; Gerron GG; Bleier J
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1052-7. PubMed ID: 7130336
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The relationship of the urinary cations, Calcium, Magnesium, Sodium and Potassium, in patients with Renal Calculi.
    Welshman SG; McGeown MG
    Br J Urol; 1975 Jun; 47(3):237-42. PubMed ID: 1139114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
    Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
    Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Urinary Lithogenic Risk Profile in ADPKD Patients Treated with Tolvaptan.
    Bargagli M; Dhayat NA; Anderegg M; Semmo M; Huynh-Do U; Vogt B; Ferraro PM; Fuster DG
    Clin J Am Soc Nephrol; 2020 Jul; 15(7):1007-1014. PubMed ID: 32527945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does green tea consumption increase urinary oxalate excretion? Results of a prospective trial in healthy men.
    Chen K; Chen D; Lan C; Liang X; Zeng T; Huang J; Duan X; Kong Z; Li S; Tiselius HG; Gurioli A; Lu X; Zeng G; Wu W
    Int Urol Nephrol; 2018 Jan; 50(1):29-33. PubMed ID: 29052087
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects.
    Glauser A; Hochreiter W; Jaeger P; Hess B
    Nephrol Dial Transplant; 2000 Oct; 15(10):1580-7. PubMed ID: 11007825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO; Schmiedl A; Wipplinger J
    Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of prevalent hypertension with 24-hour urinary excretion of calcium, citrate, and other factors.
    Taylor EN; Mount DB; Forman JP; Curhan GC
    Am J Kidney Dis; 2006 May; 47(5):780-9. PubMed ID: 16632016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Urinary excretion of calcium, magnesium, phosphate, citrate, oxalate, and uric acid by healthy schoolchildren using a 12-h collection protocol.
    Sáez-Torres C; Rodrigo D; Grases F; García-Raja AM; Gómez C; Lumbreras J; Frontera G
    Pediatr Nephrol; 2014 Jul; 29(7):1201-8. PubMed ID: 24519097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Short-Term Changes in Urinary Relative Supersaturation Predict Recurrence of Kidney Stones: A Tool to Guide Preventive Measures in Urolithiasis.
    Ferraro PM; Ticinesi A; Meschi T; Rodgers A; Di Maio F; Fulignati P; Borghi L; Gambaro G
    J Urol; 2018 Nov; 200(5):1082-1087. PubMed ID: 29940247
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low urine citrate excretion as main risk factor for recurrent calcium oxalate nephrolithiasis in males.
    Cupisti A; Morelli E; Lupetti S; Meola M; Barsotti G
    Nephron; 1992; 61(1):73-6. PubMed ID: 1528345
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Significance of the calcium to creatinine concentration ratio of a single-voided urine specimen in patients with hypercalciuric urolithiasis.
    Matsushita K; Tanikawa K
    Tokai J Exp Clin Med; 1987 Sep; 12(3):167-71. PubMed ID: 3454077
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urinary citrate excretion in patients with renal calculi.
    Menon M; Mahle CJ
    J Urol; 1983 Jun; 129(6):1158-60. PubMed ID: 6854790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of dietary factors on the risk of urinary stone formation.
    Hesse A; Siener R; Heynck H; Jahnen A
    Scanning Microsc; 1993 Sep; 7(3):1119-27; discussion 1127-8. PubMed ID: 8146611
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of Ramadan fasting on urinary risk factors for calculus formation.
    Miladipour AH; Shakhssalim N; Parvin M; Azadvari M
    Iran J Kidney Dis; 2012 Jan; 6(1):33-8. PubMed ID: 22218117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Study of inhibitor and nucleator activities in calcium stone formers.
    Duranti E; Imperiali P; Badii M; Capiccioni S; Masi MG; Sasdelli M
    Proc Eur Dial Transplant Assoc; 1983; 20():445-9. PubMed ID: 6657667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimum nutrition for kidney stone disease.
    Heilberg IP; Goldfarb DS
    Adv Chronic Kidney Dis; 2013 Mar; 20(2):165-74. PubMed ID: 23439376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.